iTeos Therapeutics Inc.

NASDAQ: ITOS · Real-Time Price · USD
10.11
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
10.11
0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

iTeos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-134.41M -112.64M 96.65M 214.52M
Depreciation & Amortization
1.24M 898K 803K 603K
Stock-Based Compensation
29.94M 27.02M 21.56M 13.79M
Other Working Capital
20.06M -9.45M -231.25M 281.93M
Other Non-Cash Items
-13.59M -7.2M -1.72M 12K
Deferred Income Tax
n/a -3.04M n/a n/a
Change in Working Capital
18.65M -8.8M -228.49M 284.21M
Operating Cash Flow
-98.18M -103.76M -111.19M 513.14M
Capital Expenditures
-1.63M -2.97M -938K -1.18M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-520.8M -290.54M -445M n/a
Sales Maturities Of Investments
391.31M 366.26M n/a n/a
Other Investing Acitivies
-25K -99K -120K -61K
Investing Cash Flow
-131.15M 72.66M -446.06M -1.24M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.25M n/a 1.06M 716K
Financial Cash Flow
122.24M 1.11M 1.98M 3.66M
Net Cash Flow
-109.02M -33.59M -563.8M 512.38M
Free Cash Flow
-99.81M -106.72M -112.13M 511.96M